UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

Arginine deprivation as a targeted therapy for cancer

Current pharmaceutical design, 2008-04, Vol.14 (11), p.1049

2008

Volltextzugriff (PDF)

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

British journal of cancer, 2012-04, Vol.106 (9), p.1481-1485

2012

Volltextzugriff (PDF)

Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma

Current molecular medicine, 2010-06, Vol.10 (4), p.405

2010

Volltextzugriff (PDF)

Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents

Oncogene, 2016-03, Vol.35 (13), p.1632-1642

2016

Volltextzugriff (PDF)

Safety, efficacy, and outcomes of transarterial chemo-infusion for hepatocellular carcinoma in patients with poor hepatic function

Journal of vascular and interventional radiology, 2016-03, Vol.27 (3), p.S213-S213

2016

Volltextzugriff (PDF)

Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Melanoma

Journal of clinical oncology, 2002-01, Vol.20 (1), p.125-133

Agarwala, S. S.

2002

Volltextzugriff (PDF)

Autoantibodies against retinal bipolar cells in cutaneous melanoma- associated retinopathy

Investigative ophthalmology & visual science, 1993-01, Vol.34 (1), p.91-100

1993

Volltextzugriff (PDF)

Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group Study

JNCI : Journal of the National Cancer Institute, 1995-11, Vol.87 (22), p.1710-1713

1995

Volltextzugriff (PDF)

Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor

European journal of cancer (1990), 2020-10, Vol.138, p.S2-S3

2020

Volltextzugriff (PDF)

529MO Activity, safety and circulating tumour DNA (ctDNA) dynamics of paradox breaker BRAF inhibitor PLX8394 in patients with advanced cancer

Annals of oncology, 2020-09, Vol.31, p.S465-S465

2020

Volltextzugriff (PDF)

Abstract No. 479 - Safety, efficacy, and outcomes of transarterial chemo-infusion for hepatocellular carcinoma in patients with poor hepatic function

Journal of vascular and interventional radiology, 2016-03, Vol.27 (3), p.S213-S213

2016

Volltextzugriff (PDF)

A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma

Cancer, 2000-02, Vol.88 (3), p.584-588

2000

Volltextzugriff (PDF)

A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix : a Gynecologic Oncology Group Study

American journal of clinical oncology, 1993-12, Vol.16 (6), p.506-508

1993

Volltextzugriff (PDF)

A Phase II Study of Intraperitoneal Cisplatin and Thiotepa in Residual Ovarian Carcinoma: A Gynecologic Oncology Group Study

Gynecologic oncology, 1998-12, Vol.71 (3), p.410-415

1998

Volltextzugriff (PDF)

CS-03 UTILIZING COLLAGEN AND DISCOIDIN DOMAIN RECEPTOR SIGNALING AS A NEWTHERAPEUTIC STRATEGY IN HUMAN MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v51-v51

2014

Volltextzugriff (PDF)

Multidrug-resistant gene expression in small-cell lung cancer

American journal of clinical oncology, 1997-08, Vol.20 (4), p.398-403

1997

Volltextzugriff (PDF)

Determining argininosuccinate synthetase (ASS) expression in patients with melanoma treated with arginine depleting therapy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10627-10627

2011

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma

Neuro-oncology (Charlottesville, Va.), 2003-04, Vol.5 (2), p.96-103

Prados, M. D.

2003

Volltextzugriff (PDF)

Phase II study of vinorelbine with low dose prednisone in the treatment of hormone-refractory metastatic prostate cancer

Oncology reports, 2003-07, Vol.10 (4), p.885

2003

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule

Cancer chemotherapy and pharmacology, 2002-09, Vol.50 (3), p.223-229

2002

Volltextzugriff (PDF)

Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration

Journal of clinical oncology, 1991-03, Vol.9 (3), p.464-467

1991

Volltextzugriff (PDF)

Arginine deprivation therapy for malignant melanoma

Clinical pharmacology: advances and applications, 2013-01, Vol.5 (default), p.11-19

2013

Volltextzugriff (PDF)

A novel concept of adoptive immunotherapy using interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e13006-e13006

2011

Volltextzugriff (PDF)

Final results of phase II trial of pegylated arginine deiminase (ADI-PEG20) in metastatic melanoma (MM)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8528-8528

2010

Volltextzugriff (PDF)

A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancer

American journal of clinical oncology, 1999-08, Vol.22 (4), p.375-380

1999

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Englisch
(162)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Humans
(113)
Science & Technology
(108)
Life Sciences & Biomedicine
(107)
Oncology
(91)
Male
(84)
Middle Aged
(82)
Female
(78)
Biological And Medical Sciences
(75)
Adult
(74)
Medical Sciences
(74)
Aged
(65)
Pharmacology. Drug Treatments
(56)
Antineoplastic Agents
(55)
Chemotherapy
(44)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Drug Evaluation
(24)
Brain Neoplasms - Drug Therapy
(22)
Aged, 80 And Over
(17)
Cisplatin - Administration & Dosage
(17)
Neurosciences & Neurology
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Arginine deprivation as a targeted therapy for cancer

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma

Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents

Safety, efficacy, and outcomes of transarterial chemo-infusion for hepatocellular carcinoma in patients with poor hepatic function

Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Melanoma

Autoantibodies against retinal bipolar cells in cutaneous melanoma- associated retinopathy

Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group Study

Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor

529MO Activity, safety and circulating tumour DNA (ctDNA) dynamics of paradox breaker BRAF inhibitor PLX8394 in patients with advanced cancer

Abstract No. 479 - Safety, efficacy, and outcomes of transarterial chemo-infusion for hepatocellular carcinoma in patients with poor hepatic function

A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma

A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix : a Gynecologic Oncology Group Study

A Phase II Study of Intraperitoneal Cisplatin and Thiotepa in Residual Ovarian Carcinoma: A Gynecologic Oncology Group Study

CS-03 UTILIZING COLLAGEN AND DISCOIDIN DOMAIN RECEPTOR SIGNALING AS A NEWTHERAPEUTIC STRATEGY IN HUMAN MALIGNANT GLIOMA

Multidrug-resistant gene expression in small-cell lung cancer

Determining argininosuccinate synthetase (ASS) expression in patients with melanoma treated with arginine depleting therapy

A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma

Phase II study of vinorelbine with low dose prednisone in the treatment of hormone-refractory metastatic prostate cancer

Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule

Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration

Arginine deprivation therapy for malignant melanoma

A novel concept of adoptive immunotherapy using interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma

Final results of phase II trial of pegylated arginine deiminase (ADI-PEG20) in metastatic melanoma (MM)

A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancer

Suchergebnisse filtern